John M. Dopp, PharmD, MS, Associate Professor, School of Pharmacy; clinical pharmacist, Wisconsin Sleep Center; University of Wisconsin-Madison in Madison, Wisconsin

At the completion of this activity, the participant will be able to:

Describe the incidence, etiology, and risk factors associated with excessive daytime sleepiness (EDS) in those with narcolepsy and obstructive sleep apnea (OSA)

Identify the recommended treatments for EDS associated with narcolepsy and OSA, including pharmacologic and nonpharmacologic options

Evaluate clinical safety and efficacy data for emerging therapies, including mechanisms of action and potential adverse effects

Explain the role of the pharmacist in identifying and treating EDS in those with narcolepsy and OSA

Publications

Sleep

® Sleep Resource Center is a comprehensive resource for clinical news and expert insights on issues related to sleep disorders, including insomnia, restless legs syndrome, narcolepsy, and sleep apnea.

September 2019 Pain Management

Pharmacy Times

Solutions for managing daytime sleepiness in patients with excessive sleep issues.

Safely and Effectively Managing Excessive Daytime Sleepiness in Patients with Narcolepsy and Sleep Apnea